Eric Topol

Eric Topol

Creator
0 followers

Cardiologist and digital medicine researcher; leading voice on biotech and healthcare innovation.

Statins Save Lives, Yet Raise Diabetes and Myopathy Risks
SocialJun 20, 2026

Statins Save Lives, Yet Raise Diabetes and Myopathy Risks

I'm very pro-statins for their incontrovertible benefit vs atherosclerotic buildup and reduction of cardiovascular adverse events. Their benefits greatly overrides the risks. However, I always keep in mind 2 key side-effects: 1. Inducing Type 2 diabetes, uncommon, but more likely with aggressive...

By Eric Topol
New Nature Papers Hint at AI's Expanding Medical Role
SocialJun 19, 2026

New Nature Papers Hint at AI's Expanding Medical Role

AI in medicine is moving rapidly to take on much broader tasks than ever, some not fully envisioned. It's not proven in real medicine yet, but the results of the 2 new @Nature papers this week foreshadow where we may...

By Eric Topol
New Research Advances Medical Reasoning Toward Real-World Care
SocialJun 19, 2026

New Research Advances Medical Reasoning Toward Real-World Care

Yes, these new papers I reviewed are pushing toward medical reasoning in order to provide diagnosis to treatment care. Still in the simulation of practice phase, but moving towards tests in a real medical environment.

By Eric Topol
Aging Impairs Brain’s Waste‑Clearance Glymphatic Flow
SocialJun 18, 2026

Aging Impairs Brain’s Waste‑Clearance Glymphatic Flow

Non-invasive imaging of the brain's glymphatic system, responsible for clearing waste products from the brain. Its flow gets impaired with aging, as shown in the mouse model @ScienceAdvances https://t.co/I6gczpjShm

By Eric Topol
AI Reads Brain Health From Retinal Photos
SocialJun 18, 2026

AI Reads Brain Health From Retinal Photos

If you want to know a lot about a person's brain health, it's embedded in a retina photo, deciphered by AI https://t.co/3xN8k8R6CX @LancetDigitalH https://t.co/B4ucfC1Nek

By Eric Topol
New AI Models Deliver End-to-End Emergency to Outpatient Care
SocialJun 17, 2026

New AI Models Deliver End-to-End Emergency to Outpatient Care

Today @Nature published 2 new AI medical agentic models that take capabilities to a new level, from end-to-end care after presentation to the emergency department and longitudinally through 3 out-patient visits. There's a lot to unpack. Summarized in a new Ground...

By Eric Topol
Resistance Training Cuts Women's Heart Disease Risk
SocialJun 17, 2026

Resistance Training Cuts Women's Heart Disease Risk

In 2 large cohorts of women, resistance training was associated with reduction of cardiovascular disease, and additive to aerobic exercise and low sedentary time https://t.co/b8U7DiBf55 https://t.co/90ZZHK0EHB

By Eric Topol
Heat Shock Proteins Buffer Mutations, Explaining Variable Disease Risk
SocialJun 17, 2026

Heat Shock Proteins Buffer Mutations, Explaining Variable Disease Risk

Why do some people with a pathogenic (disease-causing) mutation get hit and others are resilient? One explanation is heat shock proteins (like HSP90) , molecular chaperones that have a buffering, protective impact. https://t.co/actqJ0ucvI https://t.co/Kex1FgG1ME

By Eric Topol
Aging Weakens Immunity; Restore Without Autoimmunity
SocialJun 16, 2026

Aging Weakens Immunity; Restore Without Autoimmunity

Our immune response loses its integrity and protection as we age. If we're going to promote healthspan, we'll need to counter that loss of function and, at the same time, avoid inducing autoimmune diseases A new @jclinicalinvest review, open-access...

By Eric Topol
Daraxonrasib's Pancreatic Cancer Success Signals Wider Oncology Wins
SocialJun 14, 2026

Daraxonrasib's Pancreatic Cancer Success Signals Wider Oncology Wins

The recent impressive drug (daraxonrasib) success vs pancreatic cancer may presage a much broader set of wins. gift link @TheEconomist https://t.co/8bxGbwz6We https://t.co/mBiUIQMyDc

By Eric Topol
One‑Shot CRISPR Cures Hereditary Angioedema in Phase 3
SocialJun 13, 2026

One‑Shot CRISPR Cures Hereditary Angioedema in Phase 3

A life-threatening inherited disease, hereditary angioedema, with striking benefit from one-shot CRISPR genome editing. Phase 3 randomized, double-blind trial results @NEJM today https://t.co/pT4fVgZcNP https://t.co/TveFMeK9ia

By Eric Topol
Study Shows Cancer Can Be Predicted Five Years Early
SocialJun 13, 2026

Study Shows Cancer Can Be Predicted Five Years Early

What if we could predict cancer 5+ years ahead and prevent it? A new landmark study shows the way https://t.co/vRpESU3j8D

By Eric Topol
DNMT3A Mutations Drive Hyper‑methylation, Accelerating Age‑related Diseases
SocialJun 12, 2026

DNMT3A Mutations Drive Hyper‑methylation, Accelerating Age‑related Diseases

Getting to the root of age-related diseases. By studying a rare accelerated aging genetic disorder, gain-of-function mutations of DNMT3A were found to be causal. DNA hyper-methylation was then linked to stem cells dysfunction and multiple age-related diseases (blood, bone, metabolic). Work...

By Eric Topol
IL‑17/IL7R Identified as Central Immune Disease Drivers
SocialJun 12, 2026

IL‑17/IL7R Identified as Central Immune Disease Drivers

Interleukin-17 (IL-17 and its receptor, IL7R) is emerging as a key mediator in many immune-related diseases. Today @SciImmunology a superb review https://t.co/QjRc9cr9Wl https://t.co/86y5bM46p5

By Eric Topol